Muttreja P, Singh S. Family planning in India: the way forward. Indian J Med Res. 2018;148:S1–9.
Article
PubMed
PubMed Central
Google Scholar
Family Planning 2020. www.familyplanning2020.org.
Dereuddre R, Van de Velde S, Bracke P. Gender inequality and the ‘east-West’divide in contraception: an analysis at the individual, the couple, and the country level. Soc Sci Med. 2016;161:1–2.
Article
PubMed
Google Scholar
Handelsman D, Waites G. Traditional methods. In: Schill WB, Comhaire FH, Hargreave TB, editors. Andrology for the clinician. Berlin, Heidelberg: Springer; 2006. p. 122–124.
Shih G, Turok DK, Parker J. Vasectomy: the other (better) form of sterilization. Contraception. 2011;83:310–5.
Article
PubMed
Google Scholar
Brown S. They think it's all up to the girls: gender, risk and responsibility for contraception. Cult Hlth Sexual. 2015;17:312–25.
Article
Google Scholar
Kogan P, Wald M. Male contraception: history and development. Urolog Clin. 2014;41:145–61.
Google Scholar
Eberhardt J, van Wersch A, Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. BMJ Sexual Reprod Hlth. 2009;35:161–5.
Google Scholar
Hartmann B. Reproductive rights and wrongs: the global politics of population control. Chicago, Illinois: Haymarket Books, South End Press; 1995.
Rogow D, Horowitz S. Withdrawal: a review of the literature and an agenda for research. Stud Fam Plan. 1995;26:140–53.
Article
CAS
Google Scholar
Jones RE. Contraception. In: Jones RE and Lopez KH, editors. Human reproductive biology. California, USA: Academic Press; 1997; p. 271–297.
Grady WR, Klepinger DH, Billy JO, Tanfer K. Condom characteristics: the perceptions and preferences of men in the United States. Fam Plan Perspect. 1993;25:67–73.
Article
CAS
Google Scholar
Finn R. Male contraceptive methods are in the pipeline. Ob Gyn News. 2007;42:28.
Google Scholar
Amory JK, Page ST, Bremner WJ. Recent advances in male hormonal contraception. Nat Clin Pract Endocrinol Metab. 2006;2:32–41.
Article
CAS
PubMed
Google Scholar
Gava G, Meriggiola MC. Update on male hormonal contraception. Ther Adv Endocrinol Metab. 2019;10:1–9.
Article
Google Scholar
Reynolds-Wright JJ, Anderson RA. Male contraception: where are we going and where have we been? BMJ Sexual Reprod Hlth. 2019;45:236–42.
Article
Google Scholar
Kaur K, Vijay P. Immunocontraceptives: new approaches to fertility control. Biomed Res Int. 2014;868196. https://doi.org/10.1155/2014/868196.
Google Scholar
Naz RK. Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide. Protein Sci. 2014;23:857–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zaneveld LJD, Depel W, Burns JW, Shapiro S, Beyler S. Development of a potentially reversible vas deferens occlusion device and evaluation in primates. Fertil Steril. 1998;49:527–33.
Article
Google Scholar
Zaneveld LJD, De Castro MP, Faria G, Derrick F, Ferraro R. The soft, hollow plug (Shug): A potentially reversible vas deferens occlusive device. In: Rajalakshmi M, Griffin PD, editors. Male contraception: Present and Future. New Delhi, India: New Age Int (P) Ltd; 1999. p. 293–307.
Wespes E. Vasectomy in male contraception and its reversal. Europ Urol Suppl. 2014;13:68–72.
Article
Google Scholar
Li SQ, Goldstein M, Zhu J, Huber D. The no-scalpel vasectomy. J Urol. 1991;145:341–4.
Article
CAS
PubMed
Google Scholar
Monoski MA, Li PS, Baum N, Goldstein M. No-scalpel, no-needle vasectomy. Urology. 2006;68:9–14.
Article
PubMed
Google Scholar
Guha SK. Contraceptive for use by a male. 1996. USA Patent No. 5,488,075.
Lohiya NK, Alam I, Hussain M, Khan S, Ansari AS. RISUG: An intravasal injectable male contraceptive. Indian J Med Res. 2014;140:S63–72.
Levy DA, Khouader S, Leynadier F. Allergy to latex condoms. Allergy. 1998;53:1107–8.
Article
CAS
PubMed
Google Scholar
Mo ZN, Huong X, Zhang SC, Yang JR. Early and long term effects of vasectomy on serum testosterone, dehydrotestosterone, luteinizing hormone and follicle stimulating hormone levels. J Urol. 1995;154:2065–9.
Article
CAS
PubMed
Google Scholar
Schwingl PJ, Guess HA. Safety and effectiveness of vasectomy. Fertil Steril. 2000;73:923–36.
Article
CAS
PubMed
Google Scholar
Aradhya KW, Best K, Sokal DC. Recent developments in vasectomy. Br Med J. 2005;330:296–9.
Article
Google Scholar
Ansbacher R. Humoral sperm antibodies: a 10-year follow-up of vas-ligated men. Fertil Steril. 1981;36:222–4.
Article
CAS
PubMed
Google Scholar
Eisenberg ML, Walsh TJ, Turek PJ. Use of viscoelastic solution to improve visualization during urologic microsurgery: evaluation of patency after vasovasostomy. Urology. 2009;73:134–6.
Article
PubMed
Google Scholar
Schwarzer JU, Steinfatt H. Current status of vasectomy reversal. Nat Rev Urol. 2013;10:195–205.
Article
PubMed
Google Scholar
Kuang C. Beyond the male pill. Popular Science May. 2008;20. http://www.popsci.com/scitech/article/2008-05/beyond-male-pill.
Misro MM, Guha SK, Singh H, Mahajan S, Ray AR, Vasudevan P. Injectable non-occlusive chemical contraception in the male-I. Contraception. 1979;20:467–73.
Article
CAS
PubMed
Google Scholar
Gifford B. The revolutionary new birth control method for men. Wired April. 2011;26 http://www.wired.com/magazine/2011/04/ff_vasectomy/all/1.
Misro MM, Kaur H, Mahajan S, Guha SK. An intravasal non-occlusive contraceptive device in rats. J Reprod Fert. 1982;65:9–13.
Article
CAS
Google Scholar
Lohiya NK, Alam I, Ansari AS. Male Contraception. In: Kumar A, Sharma M, editors. Basics of human Andrology. Singapore: Springer; 2017. p. 493–508.
Chapter
Google Scholar
Guha S, Ansari S, Anand S, Farooq A, Misro M, Sharma D. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer. Contraception. 1985;32:109–18.
Article
CAS
PubMed
Google Scholar
Fraczek M, Kurpisz M. The redox system in human semen and peroxidative damage of spermatozoa. Postepy Hig Med Dosw. 2005;59:523–34.
Google Scholar
Lemkecher T, Dartigues S, Vaysse J, et al. Leucocytospermia, oxidative stress and male fertility: facts and hypotheses. Gynecol Obstet Fertil. 2005;33:2–10.
Article
CAS
PubMed
Google Scholar
Aitken RJ, Baker MA. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol. 2006;250:66–9.
Article
CAS
PubMed
Google Scholar
Guha SK, inventor. Styrene maleic anhydride based formulation for male contraception and prostate cancer. United States patent application US 12/736,112. 2011 Jan 6.
Chaki S, Das H, Misro MM. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG. Contraception. 2003;67:73–8.
Article
CAS
PubMed
Google Scholar
Verma K, Misro MM, Singh H, Mahajan S, Ray AR, Guha SK. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive. J Reprod Fert. 1981;63:539–42.
Article
CAS
Google Scholar
Sethi N, Srivastava RK, Singh RK. Male mediated teratogenic potential evaluation of new antifertility compound SMA in rabbit (Oryctolagus cuniculus). Contraception. 1990;42:215–23.
Article
CAS
PubMed
Google Scholar
Sethi N, Srivastava RK, Singh RK, Bhatia GS, Sinha N. Chronic toxicity of styrene maleic anhydride, a male contraceptive, in rhesus monkeys (Macaca mulatta). Contraception. 1990;42:337–47.
Article
CAS
PubMed
Google Scholar
Guha SK. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive. Asian J Androl. 2007;9:221–7.
Article
PubMed
Google Scholar
Lohiya NK, Manivannan B, Mishra PK. Ultrastructural changes in the spermatozoa of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride. Contraception. 1998;57:125–32.
Article
CAS
PubMed
Google Scholar
Mishra PK, Manivannan B, Pathak N, et al. Status of spermatogenesis and sperm parameters in langur monkeys following long-term vas occlusion with styrene maleic anhydride. J Androl. 2003;24:501–9.
Article
PubMed
Google Scholar
Guha SK, Singh G, Anand S, Ansari S, Kumar S, Koul V. Phase I clinical trial of an injectable contraceptive for the male. Contraception. 1993;48:367–75.
Article
CAS
PubMed
Google Scholar
Guha SK, Singh G, Ansari S, et al. Phase II clinical trial of a vas deferens injectable contraceptive for the male. Contraception. 1997;56:245–50.
Article
CAS
PubMed
Google Scholar
Indian Council of Medical Research (ICMR), New Delhi, Annual Report, 2016–2017.; p. 89. (https://www.icmr.nic.in/sites/default/files/annual_repoorts/ICMR_AR_English_2016_17.pdf). Accessed 30 Dec 2019.
Indian Council of Medical Research (ICMR), New Delhi, Annual Report, 2017–2018. p. 70 (https://www.icmr.nic.in/sites/default/files/annual_repoorts/ICMR_AR_English_2017-18_final.pdf). Accessed 30 Dec 2019.
Guha SK, Singh G, Srivastava A, et al. Two-year clinical efficacy trial with dose variations of a vas deferens injectable contraceptive for the male. Contraception. 1998;58:165–74.
Article
CAS
Google Scholar
Indian Council of Medical Research (ICMR), New Delhi, Annual Report, 2011–2012; p. 112. (https://www.icmr.nic.in/sites/default/files/annual_repoorts/Annual-Report-2011-2012-English.pdf). Accessed 30 Dec 2019.
Sharma RS, Mathur AK, Singh R, et al. Safety and efficacy of an intravasal, one-time injectable and non-hormonal male contraceptive (RISUG): a clinical experience. Indian J Med Res. 2019;150:81–6.
Article
PubMed
PubMed Central
Google Scholar
Sethi N, Srivastava RK, Singh RK. Histological changes in the vas deferens of rats after injection of a new male antifertility agent “SMA” and its reversibility. Contraception. 1990;41:333–9.
Article
CAS
PubMed
Google Scholar
Lohiya NK, Suthar R, Khandelwal A, Goyal S, Ansari AS, Manivannan B. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal. Int J Androl. 2010;33:e198–206.
Article
CAS
PubMed
Google Scholar
Koul V, Srivastav A, Guha SK. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats. Contraception. 1998;58:227–31.
Article
CAS
PubMed
Google Scholar
Ansari AS, Hussain M, Khan SR, Lohiya NK. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception. Andrology. 2016;4:306–13.
Article
CAS
PubMed
Google Scholar
Ansari AS, Alam I, Hussain M, Khan SR, Lohiya NK. Evaluation of genotoxicity in leukocytes and testis following intra-vasal contraception with RISUG and its reversal by DMSO and NaHCO3 in Wistar albino rats. Reprod Toxicol. 2013;36:53–9.
Article
CAS
PubMed
Google Scholar
Ansari AS, Hussain M, Khan SR, Badar A, Lohiya NK. Toxicity and mutagenicity evaluation following RISUG® contraception reversal in rats. Int J Toxicol. 2018;20:1–9.
Ansari AS, Badar A, Balasubramanian K, Lohiya NK. Contraception with RISUG® and functional reversal through DMSO and NaHCO3 in male rabbits. Asian J Androl. 2017;19(3):89–95.
Ansari AS, Badar A, Lohiya NK. Safety evaluation through genotoxicity and apoptotic markers following RISUG® induced contraception and its reversal in male rabbits. Reprod Toxicol. 2018;81:84–92.
Article
CAS
PubMed
Google Scholar
Lohiya NK, Manivannan B, Mishra PK, Pathak N, Balasubramanian SPA. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus). Contraception. 1998;58:119–28.
Article
CAS
PubMed
Google Scholar
Lohiya NK, Manivannan B, Mishra PK. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys. Int J Androl. 2000;23:36–42.
Article
CAS
PubMed
Google Scholar
Lohiya NK, Manivannan B, Bhande SS, Panneerdoss S, Garg S. Perspectives of contraceptive choices for men. Indian J Exp Bio. 2005;43:1042–7.
CAS
Google Scholar
Manivannan B, Mishra PK, Lohiya NK. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal. Contraception. 1999;59:137–44.
Article
CAS
PubMed
Google Scholar
Manivannan B, Bhande SS, Panneerdoss S, Sriram S, Lohiya NK. Safety evaluation of long-term vas occlusion with styrene maleic anhydride and its non-invasive reversal on accessory reproductive organs in langurs. Asian J Androl. 2005;7:195–204.
Article
CAS
PubMed
Google Scholar
Guha SK. RISUG™ (reversible inhibition of sperm under guidance)–an antimicrobial as male vas deferens implant for HIV free semen. Med Hypotheses. 2005;65:61–4.
Article
PubMed
Google Scholar
Banerjee S, Guha SK. RISUG®: a potential candidate for the entry inhibitor group of antiretroviral drugs. Med Hypotheses. 2009;73(2):150–2.
Article
CAS
PubMed
Google Scholar
Pal M, Bhatoa PK, Bhardwaj JC. Histo-architecture of the rabbit fallopian tube following short-term RISUG implant. Int J of Pharma Sci Res. 2014;5:903–7.
Article
CAS
Google Scholar
Ansari AS, Sevliya K, Badar A, Lohiya NK. Studies on RISUG® induced intratubular contraceptive efficacy and its reversal with DMSO and NaHCO3 in female albino rats. Int J Biomed Res. 2019; (In Press).
Dismore L, Van Wersch A, Swainston K. Social constructions of the male contraception pill: when are we going to break the vicious circle? J Health Psychol. 2016;21:788–97.
Article
PubMed
Google Scholar
Peterson LM, Campbell MA, Laky ZE. The next frontier for men's contraceptive choice: college men's willingness to pursue male hormonal contraception. Psychol Men Mascul. 2019;20:226–37.
Article
Google Scholar
Sax M, Hurley E, Rossi R, Thakore S, Hasija A, Sroga-Rios J. Young adult males perspectives of male hormonal contraception. Obstet Gynecol. 2019;133:204S. https://doi.org/10.1097/01.AOG.0000559144.%2082213.99.
Article
Google Scholar